2024 ASCO board of directors and nominating committee members elected

ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology

Cancer care is evolving at an unprecedented pace. Practitioners feel the mounting pressures daily: rising cancer rates—particularly in younger patients—a growing population of older cancer survivors, rapid growth in new care and treatment options, and navigating heightened fiscal constraints and uncertainty.

October 10, 2025

Vol.51 No.37

By Clifford A. Hudis and Thomas Kurian

Cancer Policy

ASCO report shows decrease in the number of oncologists relative to aging population

A report by the American Society of Clinical Oncology points to a growing challenge in cancer care access driven by a widening gap between the number of available oncologists and increasing patient demand.

October 10, 2025

Vol.51 No.37

By Claire Marie Porter

Capitol Hill

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Obituary

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82
Golomb was a translational scientist (before that term was in vogue)

It is with profound sadness that I announce the passing of our esteemed colleague and friend, Dr. Harvey Golomb. He died on Aug. 20.

Richard Schilsky to leave role as PI of ASCO’s TAPUR study

Richard L. Schilsky will be leaving his role as inaugural principal investigator of the American Society of Clinical Oncology-led Targeted Agent and Profiling Utilization Registry study after a decade of leadership.

September 05, 2025

Vol.51 No.32

In Brief

CancerLinQ receives ASCO-certified RQS status

Concert AI’s CancerLinQ initiative has received ASCO’s Recognized Quality Solution status—a recognition that positions the platform as a validated gateway for partnered oncology practices into ASCO’s flagship certification program.

September 05, 2025

Vol.51 No.32

2024 ASCO board of directors and nominating committee members elected

YOU MAY BE INTERESTED IN

ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology

ASCO report shows decrease in the number of oncologists relative to aging population

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82
Golomb was a translational scientist (before that term was in vogue)

Richard Schilsky to leave role as PI of ASCO’s TAPUR study

CancerLinQ receives ASCO-certified RQS status

Renew today!

Subscriber content

Never miss an issue!

Login

2024 ASCO board of directors and nominating committee members elected

YOU MAY BE INTERESTED IN

ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology

ASCO report shows decrease in the number of oncologists relative to aging population

U.S. government shuts downImpact on NCI uncertain as administration threatens more RIFs

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82Golomb was a translational scientist (before that term was in vogue)

Richard Schilsky to leave role as PI of ASCO’s TAPUR study

CancerLinQ receives ASCO-certified RQS status

Never miss an issue!

Login

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

Harvey Golomb, past chair of UChicago’s Department of Medicine, dies at 82
Golomb was a translational scientist (before that term was in vogue)